Archive · 29 Jul 2026
Johnson & Johnson Settles $5.5B Baby Powder Lawsuits
Johnson & Johnson, a well-known company, has agreed to pay $5.5 billion to settle lawsuits claiming that its baby powder causes cancer.
The lawsuits started in 2009, and the company has always said its product is safe.
The baby powder was discontinued in the US in 2020 and in other countries in 2023.
The settlement covers about 76,000 claims.
Johnson & Johnson says it wants to focus on its main healthcare business.
The company has had mixed results in court, with some wins and some losses.
The settlement needs to be approved by 95% of the claimants.
Johnson & Johnson agrees to a $5.5 billion settlement for lawsuits alleging its talc-based baby powder causes cancer.
The settlement covers approximately 76,000 claims, representing 99.75% of outstanding talc-related cases in the US.
Johnson & Johnson maintains that its products are safe and do not contain asbestos, and that the lawsuits lack scientific merit.
The baby powder was discontinued in the US in 2020 and in other countries in 2023.
The settlement needs to be approved by 95% of the claimants in state or federal courts.
- Who
- Johnson & Johnson and Kenvue Inc
- What
- Settlement of lawsuits alleging that talc-based baby powder causes cancer
- When
- Announced on 27th July 2026
- Where
- Headquartered in New Jersey, USA
- Why
- To resolve thousands of lawsuits and end expensive litigation
Plaintiffs' Claims
Johnson & Johnson's Defense
Product Safety
Plaintiffs' Claims
Plaintiffs allege that Johnson & Johnson's talc-based baby powder contains asbestos and causes ovarian cancer and mesothelioma.
Johnson & Johnson's Defense
Johnson & Johnson maintains that its products are safe, do not contain asbestos, and there is no proof that talc causes cancer.
Legal Strategy
Plaintiffs' Claims
Plaintiffs argue that Johnson & Johnson knew about the risks and lied to the public and regulatory agencies.
Johnson & Johnson's Defense
Johnson & Johnson claims that the lawsuits lack scientific merit and were sustained only by unreliable expert opinions.
Settlement
Plaintiffs' Claims
Plaintiffs see the settlement as a fair resolution to their claims.
Johnson & Johnson's Defense
Johnson & Johnson views the settlement as a way to end expensive litigation and focus on its primary healthcare business.
- Company
- Johnson & Johnson
- Product
- Talc-based baby powder
- Allegations
- Causes ovarian cancer and mesothelioma
- Settlement Amount
- $5.5 billion
- Number of Claims
- Approximately 76,000
- Date of Announcement
- 27th July 2026
- Headquarters
- New Jersey, USA
- Subsidiary Involved
- Kenvue Inc
